Synta to Present at the 8th Annual JMP Securities Healthcare Conference
Synta to Present at the 8 th Annual JMP Securities Healthcare Conference
LEXINGTON, Mass.--(BUSINESS WIRE)-- Synta Pharmaceuticals Corp. (NAS: SNTA) today announced that the Company will present at the 8th Annual JMP Securities Healthcare Conference on Wednesday, July 10, at 3:30 p.m. (EDT) in New York.
About Synta Pharmaceuticals
Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. Synta has a unique chemical compound library, an integrated discovery engine, and a diverse pipeline of clinical- and preclinical-stage drug candidates with distinct mechanisms of action and novel chemical structures. All Synta drug candidates were invented by Synta scientists using our compound library and discovery capabilities. For more information, please visit www.syntapharma.com.
Investor Relations Contact:
Synta Pharmaceuticals Corp.
George Farmer, 781-541-7213
KEYWORDS: United States North America Massachusetts New York
The article Synta to Present at the 8th Annual JMP Securities Healthcare Conference originally appeared on Fool.com.Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.